New Hormonal Agents
Showing 1 - 25 of >10,000
Prostate Cancer, Metastatic Prostate Cancer Trial in Tampa (Abiraterone, Enzalutamide, Apalutamide)
Recruiting
- Prostate Cancer
- Metastatic Prostate Cancer
- Abiraterone
- +3 more
-
Tampa, FloridaMoffitt Cancer Center
Feb 21, 2023
Metastatic Castration-Sensitive Prostate Cancer Trial in Worldwide (AZD5305, Placebo, Abiraterone Acetate)
Not yet recruiting
- Metastatic Castration-Sensitive Prostate Cancer
- AZD5305
- +4 more
-
Tucson, Arizona
- +192 more
Nov 6, 2023
Epileptic Spasms, Failed Hormonal Therapy Trial in New Delhi (Modified Atkins diet, Topiramate)
Recruiting
- Epileptic Spasms, Failed Hormonal Therapy
- Modified Atkins diet
- Topiramate
-
New Delhi, Delhi, IndiaLady Hardinge Medical College and Associated Kalawati Saran Chil
Jul 14, 2023
Based Discrete Choice Experiment Study in Prostate Cancer Study
Completed
- Prostate Cancer
- Metastatic Hormone-sensitive Prostate Cancer
-
Durham, North CarolinaDuke Clinical Research Institute
Jan 10, 2023
Learn About Novel Hormonal Therapies in People With Metastatic
Not yet recruiting
- Prostatic Neoplasms
- Novel hormonal therapy
-
New York, New YorkPfizer Inc
Oct 2, 2023
Endometriosis, Pelvic Pain Trial in Ribeirão Preto (Cannabis Derivatives, Placebo, Hormonal Contraceptive Agents)
Enrolling by invitation
- Endometriosis
- Pelvic Pain
- Cannabis Derivatives
- +2 more
-
Ribeirão Preto, Sao Paulo, BrazilCenter of Chronic Pelvic Pain and Gynecologic Endoscopy of Ribei
Dec 20, 2022
Learn About Novel Hormonal Therapies for Metastatic
Not yet recruiting
- Prostatic Neoplasms
- Novel hormonal therapy
-
New York, New YorkPfizer Inc
Nov 21, 2023
Prostate Cancer, Stage IV Prostate Cancer Trial in Tampa (Luteinizing Hormone Releasing Hormone, New Hormonal Agent, Docetaxel)
Recruiting
- Prostate Cancer
- Stage IV Prostate Cancer
- Luteinizing Hormone Releasing Hormone
- +3 more
-
Tampa, FloridaMoffitt Cancer Center
Jun 1, 2022
Prostate Cancer Trial in Bellinzona (Lifestyle intervention)
Not yet recruiting
- Prostate Cancer
- Lifestyle intervention
-
Bellinzona, SwitzerlandOncology Institute of Southern Switzerland (IOSI)
May 5, 2023
Prostate Cancer Metastatic, Prostate Cancer Trial in Worldwide (ODM-201, Placebo)
Active, not recruiting
- Prostate Cancer Metastatic
- Prostate Cancer
- ODM-201
- Placebo
-
Bordeaux, France
- +31 more
Mar 18, 2022
Spinal Cord Injuries Trial in Bronx (CPH + hand training, CD-LD + hand training, ATX + hand training)
Recruiting
- Spinal Cord Injuries
- CPH + hand training
- +3 more
-
Bronx, New YorkJames J. Peters Veterans Affairs Medical Center
Jan 23, 2023
Metastatic Castration-resistant Prostate Cancer Trial in China (olaparib, enzalutamide, abiraterone acetate)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- olaparib
- +3 more
-
Chengdu, China
- +7 more
Aug 5, 2022
Sites to Test Whether SAMANTA Questionnaire That is Used to
Completed
- Menorrhagia
- Chronic hormonal treatment
-
Multiple Locations, SpainMany locations
Mar 29, 2022
COVID-19, SARS-CoV2 Infection Trial in New Haven (Neosporin, Vaseline)
Recruiting
- COVID-19
- SARS-CoV2 Infection
- Neosporin
- Vaseline
-
New Haven, ConnecticutYale University
Sep 12, 2022
Cancer in Rheumatoid Arthritis Patients Who Use Abatacept and
Completed
- Rheumatoid Arthritis
- Non-Interventional
-
Princeton, New JerseyLocal Institution
May 16, 2022
Castration-resistant Prostate Cancer, NSCLC, Colorectal Cancer Trial in Australia, United States (SM08502, Abiraterone,
Active, not recruiting
- Castration-resistant Prostate Cancer
- +2 more
- SM08502
- +5 more
-
Tucson, Arizona
- +19 more
Oct 18, 2022
Treatment Resistant Depression, MDD, Analgesia Trial in Brooklyn (VTS-K)
Recruiting
- Treatment Resistant Depression
- +12 more
-
Brooklyn, New YorkMaimonides Medical Center
Dec 12, 2022
Mild Cognitive Impairment, Alzheimer Trial in Worldwide (Canakinumab, Placebo)
Recruiting
- Mild Cognitive Impairment
- Alzheimer Disease
- Canakinumab
- Placebo
-
Charlestown, Massachusetts
- +11 more
Nov 11, 2022
Antibacterial Agents, Ambulatory Care Trial (Feedback on RTD metric)
Not yet recruiting
- Antibacterial Agents
- Ambulatory Care
- Feedback on RTD metric
- (no location specified)
Nov 16, 2023
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)
Recruiting
- Leukemia
- +19 more
- CYNK-001
-
Denver, Colorado
- +9 more
Sep 9, 2022
Advanced Solid Tumours That Are MTAP Deficient Trial in Spain, United States (AZD3470)
Not yet recruiting
- Advanced Solid Tumours That Are MTAP Deficient
-
New Haven, Connecticut
- +3 more
Nov 8, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San
Recruiting
- Castration-Resistant Prostate Carcinoma
- +6 more
- Abemaciclib
- Lutetium Lu 177-PSMA-617
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 8, 2022